The Board of Directors of NattoPharma recommends a voluntary cash offer by Lesaffre to acquire all shares in NattoPharma.

Oslo (February 15th, 2021) – The intended acquisition recognizes the strategic and financial value of NattoPharma and its potential for the years to come.

“We are excited about the opportunities ahead, and we will continue developing and delivering world-class products to our joint customer base.” said Kjetil Ramsøy, CEO of NattoPharma.

For more information, please view link.,c3286639